March 23, 2017 5:54 PM ET

Biotechnology

Company Overview of Cerulean Pharma Inc.

Key Executives for Cerulean Pharma Inc.

NameBoard RelationshipsTitleAge
Christopher D. T. Guiffre J.D., MBA26 RelationshipsChief Executive Officer, President and Director48
Alan L. Crane M.A., M.B.A.85 RelationshipsCo-Founder and Director53
Paul A. Friedman M.D.81 RelationshipsExecutive Chairman73
Ram Sasisekharan Ph.D.48 RelationshipsCo-Founder and Member of Scientific Advisory Board51
Shiladitya Sengupta Ph.D.41 RelationshipsCo-Founder, Board Observer and Member of Scientific Advisory Board--
View More Key Executives

Cerulean Pharma Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Paul A. Friedman M.D. 81 RelationshipsMadrigal Pharmaceuticals, Inc.73
Christopher D. T. Guiffre J.D., MBA 26 RelationshipsCerulean Pharma Inc.48
Shiladitya Sengupta Ph.D. 41 RelationshipsCerulean Pharma Inc.--
Ram Sasisekharan Ph.D. 48 RelationshipsCerulean Pharma Inc.51
Alan L. Crane M.A., M.B.A. 85 RelationshipsCerulean Pharma Inc.53
View All Board Members

Cerulean Pharma Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee William T. McKee48 Relationships3 Executives
Compensation Committee M.D.Paul A. Friedman81 Relationships3 Executives
Nominating Committee Ph.D.William H. Rastetter105 Relationships2 Executives
Corporate Governance Committee Ph.D.William H. Rastetter105 Relationships2 Executives
Advisory Board Ph.D.Bruce R. Zetter76 Relationships12 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$420.2K
420.2K
320.0K
Bonus$221.9K
221.9K
244.2K
Total Short Term Compensation
Not meaningful
Total Value of Options$642.1K
642.1K
11.6M
Compensation as of Fiscal Year 2015
Cerulean Pharma Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

AntriaBio, Inc. Announces Board of Director Appointments
March 22, 2017 12:00 PM ET
Natera, Inc. Appoints Gail Marcus to Serve as Member of the Board
March 21, 2017 9:13 PM ET
Calyxt, Inc. Appoints Manoj Sahoo as the Chief Commercial Officer
March 21, 2017 8:31 PM ET
Conatus Pharmaceuticals Inc. Announces Management Changes
March 21, 2017 8:05 PM ET
Human Longevity, Inc. Appoints David Heckerman as Chief Data Scientist
March 21, 2017 5:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Cerulean Pharma Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.